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Hormone-induced changes in phospholipid metabolism were examined in a functioning rat thyroid cell line 
(FRTL-5). Stimulation of FRTL-5 cells, prelabeled with 32P, with TSH or NE resulted in a rapid decrease 
in the radioactivity of both phosphatidylinositol4,5bisphosphate (PIP3 and phosphatidylinositol Cmono- 
phosphate (PIP). The effects of TSH on phospholipid metabolism and calcium mobilization are independent 
of those on adenylate cyclase. This suggests that the TSH receptor may be unique in that it activates enzyme 
cascades involved in CAMP production and Ca2+ mobilization. 
Thyrotropin Phosphoinositide Inositol phosphate 
1. INTRODUCTION 
Regulation of FRTL-5 cells, a continuous line of 
rat thyroid cells, involves Ca*+ as well as CAMP 
second messengers [l-5]. With respect to the 
former, we have shown that TSH and NE increase 
IP3 formation from phosphoinositides [6], 
cytosolic Ca*+ levels [5] and arachidonic acid levels 
[7,8]. We have shown further that these events are 
preludes to TSH and NE stimulation of iodide ef- 
flux and the iodination of thyroglobulin [7,9]. 
The formation of IP3 has been linked to the 
hydrolysis of PIP2 with the formation of 
diacylglycerol and IP3 [ 10,111. The present report 
shows that TSH and NE induce the hydrolysis of 
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Ca2+ mobilization Phospholipid (Thyroid cell) 
PIP2 and PIP in accord with their ability to in- 
crease IP3. This occurs at very early times, consis- 
tent with other studies of ligand-mediated 
phosphoinositide/IP3/Ca*+ signals. The data thus 
remain consistent with the evidence that TSH and 
NE modulation of the phospholipid/Ca*+ signal 
system is an important aspect of regulation of 
thyroid hormone formation. 
2. MATERIALS AND METHODS 
The FRTL-5 cells (ATC CRL no.8305) used here 
were grown on 100 mm dishes (Costar, Cam- 
bridge, MA) in Coon’s modified Ham’s F-12 
medium supplemented with 5% calf serum (Grand 
Island Biological, Grand Island, NY), 1 mM 
nonessential amino acids (Microbiological 
Associates, Bethesda, MD), and a mixture of 6 
hormones or growth factors (TSH, insulin, cor- 
tisol, transferrin, glycyl-L-histidyl-L-lysine ace- 
tate, and somatostatin), as described 11,121. 
Cells were maintained in an atmosphere of 5% 
C&95% air at 37°C and the culture medium 
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changed every 3-4 days. Cells were used in these 
studies when they reached 70-80% confluency. In 
some experiments the medium was switched for 
5-7 days to medium supplemented with hormone 
mixture lacking TSH. 
To obtain cell suspensions, after aspirating the 
medium the cells were incubated in Ca2+-Mg2+- 
free Hanks’ balanced salt solution containing 
5 mM EGTA. The cells were incubated for about 
20 min in a shaking bath at 37°C and the cells then 
suspended by gently pipetting. The cells were col- 
lected by centrifugation at 500 x g, washed and 
resuspended at a density of 1 x lo6 cells/ml in low 
phosphate medium (10 PM Pod) containing 
10 mM Hepes buffer (pH 7.4) at 37°C. Cells were 
stabilized in this medium for 15 min before adding 
32Pi (10 &i/ml). The time necessary to achieve an 
isotopic steady state in the inositol-containing 
phospholipids was determined. Thereafter the cells 
were routinely labeled for 60 min before the addi- 
tion of the agonists. At various times after the ad- 
dition of the agonists a portion of the cell suspen- 
sion (0.6 ml) was quenched in 2.25 ml chloro- 
form : methanol :HCl (6 N) (100 :200 : 2) and 
extracted as described by Bligh and Dyer [13]. and 
modified by Lapetina and Michell [14]. Polyphos- 
phoinositides were separated by thin-layer chroma- 
tography on silica G plates using a solvent system 
composed of chloroform : methanol :ammonium 
hydroxide:HzO (45:45:3.5: 10) [15]. PA, PI, PC, 
and PE were separated on silica G plates using the 
two-dimensional solvent system described by 
Yavin and Sutra [16]. Lipids were visualized by 
iodine staining and radioautography. The spots 
corresponding to the lipids of interest were scraped 
into scintillation vials and 2 ml Hz0 added. The 
radioactivity was quantified from Cerenkov radia- 
tion in a liquid scintillation counter. The data are 
expressed as a percentage of control values so ex- 
periments done on different days could be com- 
pared. Experiments were repeated at least 3 times 
with duplicates done within each experiment. The 
means * SE are given. 
The TSH used in these studies was the same as 
in [ 1,3] and had a specific activity of 26 + 3 IU/mg 
in the McKenzie assay [17]. Crude TSH used in the 
tissue culture medium was obtained from Armour 
(Chicago, IL) and had a specific activity of about 
0.3 IU/mg protein. Norepinephrine was purchased 
from Sigma (St. Louis, MO). [32P]Or- 
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thophosphoric acid (carrier-free in 0.02 N HCl) 
was purchased from ICN (Irvine, CA). All other 
chemicals were obtained from commercial sources 
and the highest purity available. 
3. RESULTS 
Incorporation of 32 Pi radioactivity into PIP, 
PIP2 and PA is very rapid in FRTL-5 cells grown 
in the presence of TSH (fig.1). Isotopic 
equilibrium occurs within 1.5 h. In the absence of 
TSH, incorporation of 32Pi is reached at the same 
time, but the 32Pi incorporation attained is 
25-40070 of that in cells grown in the presence of 
TSH. 
Previous studies have shown that TSH increases 
incorporation of 32P into PI and PA [18-201. 
Here, we show that TSH causes a similar increase 
in FRTL-5 cells (fig.2). In this experiment, the cells 
were maintained without TSH for 6 days to in- 
crease sensitivity to TSH acutely. 1 h after readdi- 
tion of TSH, labeling of PI was increased by 200% 
and PA by 138% over that of unstimulated cells. 
The effect of NE on PI was more dramatic (fig.l), 
increasing PI labeling by 360% and PA 130%. 
There was no change in PC from control values 
but both TSH and NE increased labeling of PE 110 
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Fig.1. Time of incorporation of 32Pi into various 
phospholipids. 32Pi (10 &i/ml) was added to FRTL-5 
cells at time zero, and the incorporation into PI (A), PA 
(o), PIP (0), and PIP2 (0) determined as described in 
section 2 at the times indicated. Each point is the value 
of the mean + SE of a minimum of 3 separate 
experiments. 
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Fig.2. Effect of TSH and NE on 32P, incorporation into 
various phospholipids. 32Pi (10 &i/ml) was added for 
180 min to FRTL-5 cells that had been maintained in 
medium without TSH for 6 days. TSH or NE at the 
indicated final concentrations was added and the 
incubations continued for 60 min. 32Pi ncorporated into 
PI, PA, PC and PE was determined as described in 
section 2. The mean f SE is given. Experiments were 
repeated at least 2 times. 
and 140% over control values, respectively. The 
addition of 8-bromo cyclic AMP and the 
phosphodiesterase inhibitor IBMX did not affect 
lipid labeling in parallel experiments (not shown). 
As shown in fig.3, NE stimulation of FRTL-5 
cells grown in the presence of TSH resulted in a 
rapid decrease in the amount of 32P radioactivity 
found in PIP and PIP2. The maximum decrease is 
seen after about 1 min with a gradual return to 
baseline levels. The NE effect was an cY-adrenergic 
response since it was unaffected by propanolol but 
blocked by equimolar concentrations of phen- 
tolamine. TSH, when used at high concentrations 
(1 x lo-’ M), also stimulated breakdown of PIP2 
and PIP. The maximum decrease in these 
phospholipids was at about 30 s (fig.3). Agonists 
which increase intracellular levels of CAMP in 
these cells [3] (cholera toxin, Graves IgG) did not 
alter PIP2 or PIP labeling (nor did 8-bromo 
CAMP, dibutyryl CAMP, or IBMX). When the 
cells were labeled to equilibrium in the absence of 
TSH, the effect of 1 x lo-’ M TSH on [32P]PIP~ 
and [32P]PIP levels was similar to that shown for 
TSH in fig.3. The maximum decrease was at 
1 min; for PIP2 the mean f SE (n = 6) was 76.4 
2 9% of control and for PIP 76.1 f 7%. The 
levels of PIP2 and PIP returned to prestimulation 
values at 5 min. 
PIP 
Fig.3. Effect of TSH and NE on 32P, incorporation in 
polyphosphoinositides. 32P, was added to cells for 1 h 
prior to the addition of lo-’ M TSH or lo-’ M NE. The 
incorporation of 32Pi into PIP and PIP2 were 
determined as described in section 2 at the indicated 
times after addition of TSH (0) or NE (0). The control 
value was obtained just prior to TSH or NE addition. 
The data are expressed as a percentage of control values 
so that experiments done on different days could be 
compared. Results are the means k SE of at least 5 
separate experiments. 
4. DISCUSSION 
In this report we show that exposure of FRTL-5 
cells to either TSH or NE causes an increase in 
phospholipid metabolism as measured by an in- 
crease incorporation of 32Pi into PA and PI. The 
results establish that the enhanced turnover of 
inositol-containing phospholipids observed in 
thyroid tissues both in vivo and in vitro is pre- 
served in this functional cell line. In addition we 
show that NE and TSH produce rapid breakdown 
of PIP2 and PIP which can be measured within 
seconds. It is not surprising that NE stimulates 
breakdown of polyphosphoinositides since a- 
adrenergic receptor activation has been associated 
with increase cytosolic calcium due to the 
breakdown of PIP2 in other systems [111. The TSH 
concentration needed to effect a change in 
phospholipid metabolism is high (1 x lo-‘) com- 
pared to that needed to increase CAMP levels [l]. 
These results are however consistent with studies 
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showing high concentrations of TSH are necessary 
to increase IP3 levels, Ca’+ levels, arachidonic acid 
release, iodide efflux, and iodination of 
thyroglobulin [4,5-g]. The early effect of TSH and 
NE on PIP2 and PIP breakdown is consistent with 
Ca2+/PI turnover as an important biological signal 
for iodide efflux [4] thyroglobulin iodination [9], 
and activation of thyroid peroxidase [21]. 
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